Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome. (26th March 2019)

Record Type:: Journal Article
Title:: Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome. (26th March 2019)
Main Title:: Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome
Authors:: Engel, S
Luessi, F
Henning, B
Bittner, S
Loquai, C
Zipp, F
Abstract:
Is Part Of:: Annals of oncology. Volume 30:Number 6(2019)
Journal:: Annals of oncology
Issue:: Volume 30:Number 6(2019)
Issue Display:: Volume 30, Issue 6 (2019)
Year:: 2019
Volume:: 30
Issue:: 6
Issue Sort Value:: 2019-0030-0006-0000
Page Start:: 1014
Page End:: 1016
Publication Date:: 2019-03-26
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz114 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 11794.xml